9606 — Duality Biotherapeutics Share News
0.000.00%
Last trade - 00:00- HK$15.54bn
- HK$12.42bn
- CNY1.85bn
Brief: Duality Biotherapeutics Says Global Research And Development Collaboration And License Agreement With Genentech
Brief: Duality Biotherapeutics Obtains Acceptance From Shanghai Securities Regulatory Bureau For Counselling On Proposed RMB Share Listing
Brief: Duality Biotherapeutics Announces Share Repurchase Plan Of Up To $40 Million
Brief: Duality Biotherapeutics Approved Proposed RMB Share Issue On Sci-Tech Board
Brief: Duality Biotherapeutics Says NMPA Accepts Biologics License Application For Db-1303/Bnt323
Brief: Duality Biotherapeutics FY Revenue Rmb1.85 Billion
Brief: Duality Biotherapeutics Inc Says Si Wen Tendered Resignation As Exec Director
Brief: Duality Biotherapeutics Proposes Issue Of RMB Shares & Listing On The Sci-Tech- Board Of The Shanghai Stock Exchange
Duality Biotherapeutics hits record high on inclusion in Stock Connect programme
BioNTech rises after trial win for breast cancer drug
BioNTech, Duality score initial trial win with breast cancer precision drug (updated)
BioNTech, Duality score initial trial win with breast cancer precision drug
Brief: Duality Biotherapeutics Posts HY Adjusted Profit RMB145.9 Million
Brief: Dualitybio's Next-Generation Her3 Adc Db-1310 Granted FDA Fast Track Designation
Brief: Duality Biotherapeutics Says DB-1310 Granted FDA Fast Track Designation
China's Duality Biotherapeutics shares rise 130% in Hong Kong debut (updated)
China's Duality Biotherapeutics shares set to rise 91% in Hong Kong debut
Brief: Duality Biotherapeutics Says Final Offer Price Under Global Offering HK$94.60 Per Offer Share